Navigation Links
Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
Date:8/19/2007

of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ more than 100,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References

1 National Osteoporosis Foundation. About Osteoporosis: Fast Facts.

Available at: http://www.nof.org/osteoporosis/diseasefacts.htm

Accessed on June 7, 2007.

2 Black D, Delmas, S, Eastell R et al for the HORIZON Pivotal Fracture

Trial. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal

Osteoporosis. NEJM 2007; 356(18):1809-22.

3 U.S. Department of Health and Human Services. Bone Health and

Osteoporosis: A Report of the Surgeon General. 2004.


'/>"/>
SOURCE Novartis Pharmaceuticals Corporation

Copyright©2007 PR Newswire.

1

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. InvivoSciences receives NIH grant for heart technology
6. Medical College receives $11 million grant to study high blood pressure
7. Madison business receives $115,000 of new state biofuels funding
8. Superior receives funds for technical training
9. UWM receives state funding for plastics research
10. GEs Centricity EHR receives federal certification
11. WHIE receives state eHealth Initiative contract
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):'Extreme' genes shed light on origins of photosynthesis 2'Extreme' genes shed light on origins of photosynthesis 3UA-led study grapples with health effects of low-intensity warfare 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 2Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 3Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative 4Vertical Sleeve Gastrectomy Expert Dr Paul Cirangle Speaks at Annual American Society for Metabolic 26amp 3B Bariatric Surgery Meeting 51170 1Vertical Sleeve Gastrectomy Expert Dr Paul Cirangle Speaks at Annual American Society for Metabolic 26amp 3B Bariatric Surgery Meeting 51170 2Vertical Sleeve Gastrectomy Expert Dr Paul Cirangle Speaks at Annual American Society for Metabolic 26amp 3B Bariatric Surgery Meeting 51170 3Long Term Care Financing Must Be Part of Health Care Reform 51166 1Long Term Care Financing Must Be Part of Health Care Reform 51166 2Long Term Care Financing Must Be Part of Health Care Reform 51166 32 reproductive factors are important predictors of death from ovarian cancer 9184 12 reproductive factors are important predictors of death from ovarian cancer 9184 22 reproductive factors are important predictors of death from ovarian cancer 9184 3